(SAN MATEO, Calif.)IScribe, Inc., a provider of electronic, hand-held prescription-writing systems for doctors, is expected to announce a joint-market deal with pharmaceutical giant Johnson & Johnson. The Johnson & Johnson sales force will promote iScribe to primary-care doctors and specialists. In exchange, Johnson & Johnson will obtain the right to sponsor advertising and health information on the system. This will include Johnson & Johnson paying a sponsorship fee that will be determined by the number of physicians using the iScribe system. For more information visit www.iscribe.com.
Redefining Material Compatibility in Sterilization: Insights From AAMI TIR17:2024
March 24th 2025AAMI TIR17:2024 provides updated, evidence-based guidance on material compatibility with sterilization modalities. It offers essential insights for medical device design and ensures safety without compromising functionality.
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.
Unmasking Long COVID: Dr Noah Greenspan on Recovery, Research Gaps, and the Future of Treatment
March 18th 2025Dr Noah Greenspan discusses the evolving understanding of long COVID, current treatment strategies, diagnostic challenges, and the critical need for research and awareness in post-viral syndromes.